Heron Neutron Medical Corp. (TPE:7799)

Taiwan · Delayed Price · Currency is TWD

420.50

-17.00 (-3.89%)

At close: Oct 30, 2026

Market Cap	66.44B -38.2%
Revenue (ttm)	11.69M +482.1%
Net Income	-479.38M
EPS	-3.11
Shares Out	158.00M
PE Ratio	n/a
Forward PE	397.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	403,341
Open	438.00
Previous Close	437.50
Day's Range	407.50 - 449.50
52-Week Range	300.00 - 688.00
Beta	n/a
Analysts	Strong Buy
Price Target	841.25 (+100.06%)
Est. Earnings	Mar 12, 2027

About Heron Neutron Medical

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Employees 104

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 7799

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 7799 stock is "Strong Buy." The 12-month stock price target is $841.25, which is an increase of 100.06% from the latest price.

Price Target

$841.25

(100.06% upside)

Analyst Consensus: Strong Buy

Stock Forecasts